Condition (MeSH)
Meningomyelocele
ClinicalTrials.gov lists 58 trials for Meningomyelocele or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
58 of the 58 trials are tagged with Meningomyelocele itself; the rest are tagged with a narrower condition beneath it.
When did Meningomyelocele trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 5 |
| 2024 | 5 |
| 2023 | 2 |
| 2022 | 4 |
| 2021 | 2 |
| 2020 | 3 |
| 2019 | 5 |
| 2018 | 5 |
| 2017 | 7 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 8 trials still running at the 2026-10-09 snapshot; registered median of 33 months across 30 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Meningomyelocele trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 3 |
| Phase 1/2 | 1 |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 4 | 1 |
| Not applicable | 34 |
| Observational | 17 |
How many Meningomyelocele trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 9 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 9 |
| Completed | 23 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Meningomyelocele? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Atosiban | 1 |
| Darifenacin | 1 |
| Vibegron | 1 |
| Terbutaline | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Behavioral Treatment | 1 |
| Contrast Enhanced Voiding Urosonography with Urodynamic Testing | 1 |
| NEOX® CORD 1K® | 1 |
| CIC | 1 |
| Standard of Care Group | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Meningomyelocele trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| ETV or PV shunt placed | 20 | 1 |
| Preterm premature rupture of membranes (PPROM) | 19 | 1 |
| Spontaneous preterm labor | 15 | 1 |
| Fetal or infant death | 7 | 1 |
| Neonatal wound dehiscense at birth | 6 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Meningomyelocele? (95)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Neurodevelopmental Outcomes after Fetoscopic Myelomeningocele Repair. | The Journal of pediatrics | 2025 | Yes |
| Orthopaedic outcomes of prenatal versus postnatal repair of myelomeningocele. | Journal of pediatric orthopedics. Part B | 2022 | Yes |
| Management of neurogenic bladder dysfunction in children update and recommendations on medical treatment. | International braz j urol : official journal of the Brazilian Society of Urology | 2022 | Yes |
| Laparotomy-Assisted 2-Port Fetoscopic Repair of Spina Bifida Aperta: Report of a Single-Center Experience in Paris, France. | Fetal diagnosis and therapy | 2022 | Yes |
| Impact of the volume of the myelomeningocele sac on imaging, prenatal neurosurgery and motor outcomes: a retrospective cohort study. | Scientific reports | 2021 | Yes |
Showing 5 of 95 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.